Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prurigo pigmentosa]

B Degavre1, J J Guilhou, B Guillot

  • 1Service de Dermatologie, Hôpital Caremeau, Nîmes.

Annales De Dermatologie Et De Venereologie
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Prurigo pigmentosa, a rare skin condition, presents as recurrent rashes with reticulated pigmentation. This case highlights treatment challenges, as a Moroccan patient did not respond to standard cycline therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapy.

Annales de dermatologie et de venereologie·2025
Same author

Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.

Annales de dermatologie et de venereologie·2024
Same author

Isotretinoin: Past, present and future. A French perspective.

Annales de dermatologie et de venereologie·2024
Same author

Promoting clinical research in community-based practice: Threats and opportunities.

Annales de dermatologie et de venereologie·2024
Same author

Management of tinea capitis in children following the withdrawal of griseofulvin from the French market: A fast-track algorithm proposed by the Center of Evidence of the French Society of Dermatology.

Annales de dermatologie et de venereologie·2022
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Dermatology
  • Pathology

Background:

  • Prurigo pigmentosa is a rare dermatosis known for sudden onset, recurrent papulopururitic rashes, and characteristic reticulated trunk pigmentation.
  • Histological examination reveals a non-specific lichenoid tissue reaction, common in various inflammatory skin conditions.

Observation:

  • A case of prurigo pigmentosa in a 21-year-old Moroccan individual, noted as the seventh non-Japanese patient documented.
  • The patient presented with the typical sudden onset and recurrent nature of the condition, along with trunkal reticulated pigmentation.

Findings:

  • Standard treatment options for prurigo pigmentosa, such as dapsone, potassium iodide, and cyclines, have shown varying success rates in previous literature.
  • In this reported case, the patient's prurigo pigmentosa was refractory to treatment with cycline, indicating potential therapeutic resistance.

Related Experiment Videos

Implications:

  • This case underscores the variability in treatment response for prurigo pigmentosa, even with established therapies like cyclines.
  • Further research into alternative or combination therapies may be necessary for managing refractory cases of prurigo pigmentosa, particularly in non-Japanese populations.